This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $10,861.95, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 28, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The award, valued at $14,338.67, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 10, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $17,414.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Monovisc 88 mg/4 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,287.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,355.23 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $8,877.43, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The federal contract award described is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $10,850.70 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order contract has an ultimate completion date of April 17, 2023 and was awarded on April 15, 2023. The contract is not designated with any set-aside requirements, indicating open competition....
The federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,031.75 and is a firm fixed-price delivery order that runs through January 30, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $4,647.12, is a Delivery Order with a Firm Fixed Price pricing type. It was awarded on July 11, 2024, with a completion date of July 12, 2024. This award is...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $11,588.58, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a firm fixed-price pricing type and a completion date of June 13, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...